Skip to content

Eupraxia Pharmaceuticals Inc.

EPRX· NasdaqCore metricsCIK 1581178

Pharmaceutical preparations551 peers

Last sale
Nov 12, 2026 · -2.61%
Market cap
$472.11M
60.29M shares
Filings
132
$0.00
FY 2025
-$38.58M
FY 2025N/M FY25 yoy
—
—
—
—
—
—
-$1.03
FY 2025N/M FY25 yoy
$80.56M
FY 2025+143.4% FY25 yoy
$472.11M
—
—
5.8×
—
—

FY2025 figures · derived

Price

$7.83+19.91%+$1.30past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$0.00FY 2025
$0.000FY 2023FY 2024FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$0reported
FY 20242024-12-31$0reported
FY 20232023-12-31$0reported

Pharmaceutical preparations

Eupraxia Pharmaceuticals Inc. is the 191st largest of the 552 covered companies the SEC files under this code, by market cap. SIC 2834

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Eupraxia Pharmaceuticals Inc. · CIK 1581178 · Engraved from SEC EDGAR